rituximab,polatuzumab vedotin
roche
['polarix', 'dlbcl']
polarix trial update pola-r-chp improves pfs but not os in 1st line dlbcl.
yet, ctdna evolution under treatment correlate with pfs and os ! that s interesting ! at #ash22
cc 
YoungEHA is YOUR community for the next generation in hematology, represented by the YoungEHA committee. @EHA_Hematology #YoungEHA?? E-mail: youngeha@ehaweb.org